Continuous glucose monitoring: indications, data interpretation and making therapeutic decisions
The tools to assess the degree of glycemic control were modified lately. Glycosylated Hemoglobin (HbA1c), the gold standard, reflects the glycemic control of the last 3 months retrospectively, without expressing glycemic variability. Self-blood glucose monitoring (SBGM) provides immediate and prospe...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Sello Editorial Lugones
2020-12-01
|
| Series: | Revista de la Sociedad Argentina de Diabetes |
| Subjects: | |
| Online Access: | https://revistasad.com/index.php/diabetes/article/view/455 |
| _version_ | 1797984019283968000 |
|---|---|
| author | León Litwak Nancy Carreño Rodrigo Carnero Alejandro Dain Luis Grosembacher Carla Musso Adrián Proietti Lucas Rista Gabriela Rovira Graciela Rubin María Ruiz Antonio Saleme Liliana Trifone José Costa Gil |
| author_facet | León Litwak Nancy Carreño Rodrigo Carnero Alejandro Dain Luis Grosembacher Carla Musso Adrián Proietti Lucas Rista Gabriela Rovira Graciela Rubin María Ruiz Antonio Saleme Liliana Trifone José Costa Gil |
| author_sort | León Litwak |
| collection | DOAJ |
| description | The tools to assess the degree of glycemic control were modified lately. Glycosylated Hemoglobin (HbA1c), the gold standard, reflects the glycemic control of the last 3 months retrospectively, without expressing glycemic variability. Self-blood glucose monitoring (SBGM) provides immediate and prospective information, but has little glycemic data to generate representative averages and standard deviations. It does not detect trends and has limitations to obtain nocturnal data or during physical activity. It is invasive and often rejected. On the contrary, continuous glucose monitoring (CGM), allows to measure glucose instantly, shows your trends and variability continuously, incorporating new control metrics. |
| first_indexed | 2024-04-11T06:55:06Z |
| format | Article |
| id | doaj.art-e74df672411742c48b6635738453d5c5 |
| institution | Directory Open Access Journal |
| issn | 0325-5247 2346-9420 |
| language | Spanish |
| last_indexed | 2024-04-11T06:55:06Z |
| publishDate | 2020-12-01 |
| publisher | Sello Editorial Lugones |
| record_format | Article |
| series | Revista de la Sociedad Argentina de Diabetes |
| spelling | doaj.art-e74df672411742c48b6635738453d5c52022-12-22T04:39:03ZspaSello Editorial LugonesRevista de la Sociedad Argentina de Diabetes0325-52472346-94202020-12-0154314015410.47196/diab.v54i3.455387Continuous glucose monitoring: indications, data interpretation and making therapeutic decisionsLeón Litwak0Nancy Carreño1Rodrigo Carnero2Alejandro Dain3Luis Grosembacher4Carla Musso5Adrián Proietti6Lucas Rista7Gabriela Rovira8Graciela Rubin9María Ruiz10Antonio Saleme11Liliana Trifone12José Costa Gil13Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, ArgentinaFundación Argentina Diabetes, Ciudad Autónoma de Buenos Aires, ArgentinaInstituto Médico de Río Cuarto, Córdoba, ArgentinaClínica Universitaria Reina Fabiola de Córdoba, Córdoba, ArgentinaHospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, ArgentinaFundación Favaloro, Ciudad Autónoma de Buenos Aires, ArgentinaInstituto Integral de Diabetes y Tecnología Aplicada (IDTA), Ciudad Autónoma de Buenos Aires, ArgentinaCentro de Diabetes y Nutrición de Rosario, Presidente Fundación Paul Langerhans, Santa Fe, ArgentinaHospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires, ArgentinaHospital Privado Universitario de Córdoba, Córdoba, ArgentinaCentro Consultores en Diabetes y Enfermedades Metabólicas (CODIME), Ciudad Autónoma de Buenos Aires, ArgentinaUniversidad Favaloro, Sanatorio Santa Fe, Santa Fe, ArgentinaHospital de Niños Ricardo Gutiérrez, Ciudad Autónoma de Buenos Aires, ArgentinaUniversidad Favaloro, Ciudad Autónoma de Buenos Aires, ArgentinaThe tools to assess the degree of glycemic control were modified lately. Glycosylated Hemoglobin (HbA1c), the gold standard, reflects the glycemic control of the last 3 months retrospectively, without expressing glycemic variability. Self-blood glucose monitoring (SBGM) provides immediate and prospective information, but has little glycemic data to generate representative averages and standard deviations. It does not detect trends and has limitations to obtain nocturnal data or during physical activity. It is invasive and often rejected. On the contrary, continuous glucose monitoring (CGM), allows to measure glucose instantly, shows your trends and variability continuously, incorporating new control metrics.https://revistasad.com/index.php/diabetes/article/view/455diabetesmonitoreo continuo de glucosacontrol glucémicoinsulinoterapia intensificada. |
| spellingShingle | León Litwak Nancy Carreño Rodrigo Carnero Alejandro Dain Luis Grosembacher Carla Musso Adrián Proietti Lucas Rista Gabriela Rovira Graciela Rubin María Ruiz Antonio Saleme Liliana Trifone José Costa Gil Continuous glucose monitoring: indications, data interpretation and making therapeutic decisions Revista de la Sociedad Argentina de Diabetes diabetes monitoreo continuo de glucosa control glucémico insulinoterapia intensificada. |
| title | Continuous glucose monitoring: indications, data interpretation and making therapeutic decisions |
| title_full | Continuous glucose monitoring: indications, data interpretation and making therapeutic decisions |
| title_fullStr | Continuous glucose monitoring: indications, data interpretation and making therapeutic decisions |
| title_full_unstemmed | Continuous glucose monitoring: indications, data interpretation and making therapeutic decisions |
| title_short | Continuous glucose monitoring: indications, data interpretation and making therapeutic decisions |
| title_sort | continuous glucose monitoring indications data interpretation and making therapeutic decisions |
| topic | diabetes monitoreo continuo de glucosa control glucémico insulinoterapia intensificada. |
| url | https://revistasad.com/index.php/diabetes/article/view/455 |
| work_keys_str_mv | AT leonlitwak continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT nancycarreno continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT rodrigocarnero continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT alejandrodain continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT luisgrosembacher continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT carlamusso continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT adrianproietti continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT lucasrista continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT gabrielarovira continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT gracielarubin continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT mariaruiz continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT antoniosaleme continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT lilianatrifone continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions AT josecostagil continuousglucosemonitoringindicationsdatainterpretationandmakingtherapeuticdecisions |